Keith Crandell - 05 Feb 2026 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Director
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Keith Crandell
Issuer symbol
TWST
Transactions as of
05 Feb 2026
Net transactions value
$0
Form type
4
Filing time
09 Feb 2026, 17:34:35 UTC
Previous filing
13 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CRANDELL KEITH Director 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO /s/ Kendra Fox, as Attorney-in-Fact for Keith Crandell 09 Feb 2026 0001219039

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +5,095 +23% $0.000000 27,571 05 Feb 2026 Direct F1
holding TWST Common Stock 76,047 05 Feb 2026 By Keith L. Crandell Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.
F2 The Reporting Person and his spouse are co-trustees. The Reporting Person is the sole beneficiary of the Keith L. Crandell Trust.